CASC8 is a pioneering biotech company developing a first-in-class regenerative cell therapy that directly restores damaged heart muscle —addressing the root cause of heart failure rather than managing symptoms. With strong preclinical validation and a scalable, off-the-shelf platform, CASC8 is positioned to transform a €260B global market by shifting cardiac care from chronic treatment to true tissue repair
| Website | http://www.casc8.org |
| Employees | 4 (1 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+6 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
Looking for a particular CASC8 employee's phone or email?
1 people are employed at CASC8.